Antischistosomal efficacy of artesunate combination therapies administered as curative treatments for malaria attacks (Q33996681)

30 July 2017

Antischistosomal efficacy of artesunate combination therapies administered as curative treatments for malaria attacks (English)

1 reference

30 July 2017

0 references

0 references

10

Brian Greenwood

1 reference

30 July 2017

8

Cheikh Sokhna

1 reference

30 July 2017

9

Jean-François Trape

1 reference

30 July 2017

3

Badara Cisse

1 reference

30 July 2017

4

Franck Remoue

1 reference

30 July 2017

1

Denis Boulanger

1 reference

30 July 2017

Yemou Dieng

2

1 reference

30 July 2017

Frederic Capuano

5

1 reference

30 July 2017

Jean-Louis Dieme

6

1 reference

30 July 2017

Tofene Ndiaye

7

1 reference

30 July 2017

Francois Simondon

11

1 reference

30 July 2017

12 June 2006

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

30 July 2017

1 reference

30 July 2017

101

1 reference

30 July 2017

2

1 reference

30 July 2017

113-116

1 reference

Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.003

Coinfection with Plasmodium falciparum and schistosoma haematobium: protective effect of schistosomiasis on malaria in senegalese children?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.003

Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.003

Efficacy of artesunate and praziquantel in Schistosoma haematobium infected schoolchildren

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.003

Decline of infant and child mortality rates in rural Senegal over a 37-year period (1963-1999).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.003

Efficacy of artesunate in the treatment of urinary schistosomiasis, in an endemic community in Nigeria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.003

Association of failures of seven-day courses of artesunate in a non-immune population in Bangui, Central African Republic with decreased sensitivity of Plasmodium falciparum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.003

Controlling malaria: challenges and solutions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.003

Impact of chloroquine resistance on malaria mortality.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.003

Current progress in the development and use of artemether for chemoprophylaxis of major human schistosome parasites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.003

Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.003

Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.003

10.1016/J.TRSTMH.2006.03.003

7 January 2021

Identifiers

DOI

1 reference

30 July 2017

1 reference